Parenteral Drugs (India) Performance
- Today's Low
- ₹3
- Today's High
- ₹3
- 52 Week Low
- ₹0
- 52 Week High
- ₹3
- Open Price₹3
- Previous Close₹3
- Volume1,250
- 50 DMA₹3.47
- 100 DMA₹3.54
- 200 DMA₹3.72
Parenteral Drugs (India) Chart
Investment Returns
Smart Investing Starts Here Start SIP with Parenteral Drugs (India) for Steady Growth!
Parenteral Drugs (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -0.1
- PEG Ratio
- -0
- Market Cap Cr
- 9
- P/B Ratio
- -0
- Average True Range
- 0.15
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.2
- RSI
- 36.04
- MFI
- 3.73
Latest Stock News Updates
The positive listing of Sai Parenteral's shares defied the grey market trend, in which the counter traded almost flat.
- Business Standard
- 2 months 3 weeks ago
Noumed Pharmaceuticals is a supplier of private label over the counter products to pharmacy chains across Australia and New Zealand
- Business Line
- 6 months 3 weeks ago
NULL
- Moneycontrol
- 4 years 4 months ago
Parenteral Drugs (India) Financials
Parenteral Drugs (India) Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹3.20
- 50 Day
- ₹3.50
- 100 Day
- ₹3.50
- 200 Day
- ₹3.70
Resistance and Support
- R3 3.17
- R2 3.03
- R1 2.97
- S1 2.77
- S2 2.63
- S3 2.57
Parenteral Drugs (India) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2022-05-30 | Audited Results & Others | Inter alia, to consider : The shifting of registered office of the Company within local limits of the city. |
| 2022-02-14 | Quarterly Results | |
| 2022-02-02 | Others | inter alia, To consider appointment of Independent Director and to consider sale, lease or disposal of the whole or substantially the whole of the undertaking of the Company. |
| 2021-11-12 | Quarterly Results | |
| 2021-08-10 | Quarterly Results |
About Parenteral Drugs (India)
- NSE Symbol
- PDPL
- BSE Symbol
- 524689
- ISIN
- INE904D01019
Similar Stocks to Parenteral Drugs (India)
Popular Stocks
Parenteral Drugs (India) FAQs
Parenteral Drugs (India) share price is ₹2 As on 28 June, 2026 | 06:28
The Market Cap of Parenteral Drugs (India) is ₹8.6 Cr As on 28 June, 2026 | 06:28
The P/E ratio of Parenteral Drugs (India) is -0.1 As on 28 June, 2026 | 06:28
The PB ratio of Parenteral Drugs (India) is -0 As on 28 June, 2026 | 06:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.